Area of research
Immunology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Immune cells in cancer, Ferroptosis and cancer prognosis, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, and Chromatin Remodeling and Cancer.
Architecture of the neutrophil compartment.
From complexity to consensus: A roadmap for neutrophil classification
Spatially mapping the tumour immune microenvironments of non-small cell lung cancer.
Architecture of the neutrophil compartment
A Dock8-dependent mechanosensitive central actin pool maintains T cell shape and protects the nucleus during migration.
The impact of a high fat diet and platelet activation on pre-metastatic niche formation.
Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancer.
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.
Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function.
Cancer Hallmarks: Piecing the Puzzle Together.
Revolutionizing cancer research with spatial proteomics and visual intelligence.
Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies.
Breast Cancer Immunity: It is TIME for the Next Chapter.
Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancer.
Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Supplementary Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S1 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S5 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S3 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S1 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S3 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S4 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S4 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Supplementary Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S2 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S2 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S1 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer
Table S3 from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer